DrugPatentWatch Database Preview
OXAYDO Drug Profile
see a sample report or, see our see our flat-rate plans
When do Oxaydo patents expire, and what generic alternatives are available?
This drug has thirteen patent family members in six countries.
The generic ingredient in OXAYDO is oxycodone hydrochloride. There are nineteen drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the oxycodone hydrochloride profile page.
Summary for OXAYDO
| International Patents: | 13 |
| US Patents: | 6 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 3 |
| Bulk Api Vendors: | 8 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for OXAYDO |
| DailyMed Link: | OXAYDO at DailyMed |
Pharmacology for OXAYDO
| Drug Class | Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
US Patents and Regulatory Information for OXAYDO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Egalet Us Inc | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-001 | Jun 17, 2011 | RX | No | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Egalet Us Inc | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-002 | Jun 17, 2011 | RX | No | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Egalet Us Inc | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-001 | Jun 17, 2011 | RX | No | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Egalet Us Inc | OXAYDO | oxycodone hydrochloride | TABLET;ORAL | 202080-002 | Jun 17, 2011 | RX | No | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
Non-Orange Book US Patents for OXAYDO
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 7,476,402 | Methods and compositions for deterring abuse of opioid containing dosage forms | ➤ Sign Up |
| 8,822,489 | Abuse deterrent compositions and methods of making same | ➤ Sign Up |
| 8,101,630 | Extended release opioid abuse deterrent compositions and methods of making same | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
see a sample report or, see our see our flat-rate plans
International Patents for OXAYDO
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Australia | 2015264950 | ➤ Sign Up |
| Australia | 2013206525 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 2005053587 | ➤ Sign Up |
| Spain | 2637338 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for OXAYDO
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 292 | Luxembourg | ➤ Sign Up | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
